{"id":169697,"date":"2025-08-04T01:57:14","date_gmt":"2025-08-04T05:57:14","guid":{"rendered":"https:\/\/44.250.171.167\/?p=169697"},"modified":"2025-08-04T07:27:07","modified_gmt":"2025-08-04T11:27:07","slug":"narayana-hrudayalaya-ltd-q1-fy26-earnings-results-2-fall-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/narayana-hrudayalaya-ltd-q1-fy26-earnings-results-2-fall-in-profits\/","title":{"rendered":"Narayana Hrudayalaya Q1 FY26 Earnings Results &#8211; 2% fall in Profits"},"content":{"rendered":"<p>Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. Presenting below are its Q1 FY26 Earnings.<\/p>\n<p>&nbsp;<\/p>\n<h2 id=\"q1-fy26-earnings-summary-aprjun-2025\" class=\"mb-2 mt-6 text-base font-[500] first:mt-0 md:text-lg dark:font-[475] [hr+&amp;]:mt-4\">Q1 FY26 Earnings Results:<\/h2>\n<ul class=\"marker:text-textOff list-disc\">\n<li>\n<p class=\"my-0\"><strong>Total Income:<\/strong>\u00a0\u20b91,531 crore, up 12.2% year-over-year (YoY) and 17.5% quarter-over-quarter (QoQ)<span class=\"whitespace-nowrap\">.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"my-0\"><strong>Revenue from Operations:<\/strong>\u00a0Approximately \u20b91,507 crore, up 15.4% YoY<span class=\"whitespace-nowrap\">.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"my-0\"><strong>EBITDA:<\/strong>\u00a0\u20b9361 crore, up 10.8% YoY; EBITDA margin was 23.8%, down from 24.8% YoY<span class=\"whitespace-nowrap\">.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"my-0\"><strong>Profit Before Tax (PBT):<\/strong>\u00a0\u20b9231 crore, nearly flat YoY; up 2.5% sequentially<span class=\"whitespace-nowrap\">.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"my-0\"><strong>Profit After Tax (PAT):<\/strong> \u20b9197 crore, down 2.4% YoY but up 3.1% QoQ; net profit margin ~13%<span class=\"whitespace-nowrap\">.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"my-0\"><strong>EPS:<\/strong>\u00a0\u20b99.70 vs \u20b99.90 Q1 FY25<span class=\"whitespace-nowrap\">.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"my-0\"><strong>Key Business Segments:<\/strong><\/p>\n<ul class=\"marker:text-textOff list-disc\">\n<li>\n<p class=\"my-0\"><strong>India Revenue:<\/strong>\u00a0\u20b91,132.6 crore, up 7.8% YoY.<\/p>\n<\/li>\n<li>\n<p class=\"my-0\"><strong>Cayman Islands Revenue:<\/strong>\u00a0\u20b9396.8 crore, up 48.4% YoY.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p class=\"my-0\"><strong>Expenses:<\/strong>\u00a0\u20b91,300 crore, up 14.7% YoY.<\/p>\n<\/li>\n<li>\n<p class=\"my-0\"><strong>Net Debt:<\/strong>\u00a0\u20b9343 crore; net debt-to-equity of 0.09<span class=\"whitespace-nowrap\">.<\/p>\n<p><\/span><\/p>\n<\/li>\n<\/ul>\n<h3 id=\"key-management-commentary--operational-highlights\" class=\"mb-2 mt-6 text-base font-[500] first:mt-0 md:text-lg dark:font-[475] [hr+&amp;]:mt-4\">Key Management Commentary &amp; Operational Highlights<\/h3>\n<ul class=\"marker:text-textOff list-disc\">\n<li>\n<p class=\"my-0\">Healthy double-digit revenue growth was driven by robust performance and expansion in both India and international (Cayman Islands) operations<span class=\"whitespace-nowrap\">.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"my-0\">India business maintained steady 7\u20138% growth; new blocks and upgraded facilities contributed to clinical efficiency and increased patient intake<span class=\"whitespace-nowrap\">.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"my-0\">Cayman Islands business saw exceptional growth, with 48% YoY revenue jump, partly due to expanded service offerings and greater global patient inflow<span class=\"whitespace-nowrap\">.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"my-0\"><a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/b1687a75-614d-412d-ab58-8123b1a377b2.pdf\" target=\"_blank\" rel=\"noopener\">Margins softened slightly<\/a> due to increased costs and sustained investments in capacity, technology, and talent<span class=\"whitespace-nowrap\">.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"my-0\">The <a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/b1687a75-614d-412d-ab58-8123b1a377b2.pdf\" target=\"_blank\" rel=\"noopener\">balance sheet remains strong<\/a>, with low net leverage, enabling continued expansion.<\/p>\n<\/li>\n<li>\n<p class=\"my-0\">Management reaffirmed its long-term strategy: large-scale capex (\u20b93,000 crore planned over three years) to add 2,000 beds, invest in digital health, and deepen presence in high-acuity specialties<span class=\"whitespace-nowrap\">.<\/span><\/p>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-169703\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/prev-839x1024.png\" alt=\"Narayana Hrudyalaya Q1 FY26 Earnings Results\" width=\"640\" height=\"781\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/prev-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/prev-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/prev-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/prev-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/prev.png 1489w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/p>\n<p>&nbsp;<\/p>\n<h2 id=\"q4-fy25-earnings-snapshot-janmar-2025\" class=\"mb-2 mt-6 text-base font-[500] first:mt-0 md:text-lg dark:font-[475] [hr+&amp;]:mt-4\">Q4 FY25 Earnings:<\/h2>\n<ul>\n<li>Narayana Hrudayalaya Ltd reported <a href=\"https:\/\/44.250.171.167\/narayana-hrudayalaya-ltd-q4fy25-3-rise-in-profits\/\">Revenues for Q4 FY25<\/a> of \u20b91,475.00 Crores up from \u20b91,246.00 Crore year on year, a rise of 18.38%.<\/li>\n<li>Total <a href=\"https:\/\/44.250.171.167\/narayana-hrudayalaya-ltd-q4fy25-3-rise-in-profits\/\">Expenses for Q4 FY25<\/a> of \u20b91,241.00 Crores up from \u20b91,048.00 Crores year on year, a rise of 18.42%.<\/li>\n<li>Consolidated Net Profit of \u20b9197.00 Crores up 3.14% from \u20b9191.00 Crores in the same quarter of the previous year.<\/li>\n<li>The Earnings per Share is \u20b99.65, up 3.43% from \u20b99.33 in the same quarter of the previous year.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. Presenting below are its Q1 FY26 Earnings. &nbsp; Q1 FY26 Earnings Results: Total Income:\u00a0\u20b91,531 crore, up 12.2% year-over-year (YoY) and 17.5% quarter-over-quarter (QoQ). Revenue from Operations:\u00a0Approximately \u20b91,507 crore, up 15.4% YoY. [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":169703,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,5747],"tags":[12045,14170],"class_list":["post-169697","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-healthcare-stocks","tag-cardiology","tag-multi-specialty-hospitals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/prev.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":170356,"url":"https:\/\/alphastreet.com\/india\/shalby-q1-fy26-earnings-results\/","url_meta":{"origin":169697,"position":0},"title":"Shalby Q1 FY26 Earnings Results","author":"Chirag Gupta","date":"August 20, 2025","format":false,"excerpt":"Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Shalby Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/3-12.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/3-12.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/3-12.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/3-12.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/3-12.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/3-12.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169795,"url":"https:\/\/alphastreet.com\/india\/rossari-biotech-ltd-q1-fy26-earnings-results-3-fall-in-profits\/","url_meta":{"origin":169697,"position":1},"title":"Rossari Biotech Ltd Q1 FY26 Earnings Results &#8211; 3% fall in Profits","author":"Chirag Gupta","date":"August 6, 2025","format":false,"excerpt":"Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. Presenting below are its Q1 FY26 earnings. \u00a0 Q1 FY26 Earnings Summary Consolidated Revenue from Operations:\u00a0\u20b9543.7 crore, up 11% year-over-year (YoY) from \u20b9489.7 crore in Q1 FY25. EBITDA:\u00a0\u20b967.9 crore, up 4.6% YoY;\u00a0EBITDA\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Rossari Biotech Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/2-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/2-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/2-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/2-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/2-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/2-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":171502,"url":"https:\/\/alphastreet.com\/india\/thyrocare-q2-fy26-earnings-results\/","url_meta":{"origin":169697,"position":2},"title":"Thyrocare Q2 FY26 Earnings Results","author":"Chirag Gupta","date":"October 14, 2025","format":false,"excerpt":"Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. Presenting below are its Q2 FY26 earnings results. \u00a0 Q2 FY26 Earnings Results Revenue from operations:\u00a0\u20b9216.5 crore, up 22% YoY from \u20b9177.4\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Thyrocare Q2 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Thyrocare-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Thyrocare-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Thyrocare-Q2-FY26-Earnings-Results.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Thyrocare-Q2-FY26-Earnings-Results.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Thyrocare-Q2-FY26-Earnings-Results.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Thyrocare-Q2-FY26-Earnings-Results.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":170087,"url":"https:\/\/alphastreet.com\/india\/zydus-lifesciences-q1-fy26-earnings-results\/","url_meta":{"origin":169697,"position":3},"title":"Zydus Lifesciences Q1 FY26 Earnings Results","author":"Chirag Gupta","date":"August 12, 2025","format":false,"excerpt":"In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Zydus Lifesciences Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":170363,"url":"https:\/\/alphastreet.com\/india\/saksoft-q1-fy26-earnings-results\/","url_meta":{"origin":169697,"position":4},"title":"Saksoft Q1 FY26 Earnings Results","author":"Chirag Gupta","date":"August 20, 2025","format":false,"excerpt":"Saksoft Ltd is engaged in providing business intelligence and information management solutions predominantly to mid-tier companies based out of USA and UK. It was established in 1999 by Autar Krishna and his son Mr Aditya Krishna. Presenting below are its Q1 FY26 earnings results. \u00a0 Q1 FY26 Earnings Results Total\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Saksoft Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-14.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-14.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-14.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-14.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-14.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-14.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":172189,"url":"https:\/\/alphastreet.com\/india\/vinati-organics-q2-fy26-earnings-results\/","url_meta":{"origin":169697,"position":5},"title":"Vinati Organics Q2 FY26 Earnings Results","author":"Chirag Gupta","date":"November 6, 2025","format":false,"excerpt":"Incorporated in 1989, Vinati Organics Ltd manufactures specialty organic intermediaries and Monomers. \u00a0 Q2 FY26 Earnings Results: Revenue from Operations: \u20b9546 crore, marginally up 1.52% QoQ but down 1.26% YoY from \u20b9553.32 crore. Net Profit After Tax (PAT): \u20b9129 crore, grew 10.26% QoQ and 21.7% YoY from \u20b9104.36 crore. Operating\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Vinati Organics Q2 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Vinati-Organics-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Vinati-Organics-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Vinati-Organics-Q2-FY26-Earnings-Results.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Vinati-Organics-Q2-FY26-Earnings-Results.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Vinati-Organics-Q2-FY26-Earnings-Results.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Vinati-Organics-Q2-FY26-Earnings-Results.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/169697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=169697"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/169697\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/169703"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=169697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=169697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=169697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}